Skip to content

Clinical trials

Atypical Hemolytic Uremic Syndrome trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atypical Hemolytic Uremic Syndrome Country / region: France Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20095
20102
20121
20131
20151
20171
20213
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.11
Hoffmann-La Roche2
Assistance Publique - Hôpitaux de Paris1
Nantes University Hospital1
Novartis Pharmaceuticals1
University Hospital, Tours1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atypical Hemolytic Uremic Syndrome17
Thrombotic Microangiopathies3
Acute Kidney Injury1
Hemoglobinuria, Paroxysmal1
Hemolytic-Uremic Syndrome1
Hypertensive Crisis1
Kidney Diseases1
Kidney Failure, Chronic1
Myasthenia Gravis1
Neuromyelitis Optica1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.